CNS & Neurological Disorders - Drug Targets
Formerly: Current Drug Targets - CNS & Neurological Disorders
Volume 19, 10 Issues, 2020
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access
Ranking and Category
-
150th of 267 in
Neurosciences
-
119th of 267 in
Pharmacology & Pharmacy
Contents
CNS & Neurological Disorders - Drug Targets , Volume 14 - Number 7
Genetic Polymorphisms Might Predict Suicide Attempts in Mental Disorder Patients: A Systematic Review And Meta-Analysis
, 14(7): 820 - 827Veronica de Medeiros Alves, Daniele Goncalves Bezerra, Tiago Gomes de Andrade, Valfrido Leao de Melo Neto and Antonio E. Nardi
DOI: 10.2174/1871527314666150713104619
Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis In Vitro
, 14(7): 828 - 837Mariateresa Cipriano, Giueseppe Esposito, Luana Negro, Elena Capoccia, Giovanni Sarnelli, Caterina Scuderi, Daniele De Filippis, Luca Steardo and Teresa Iuvone
DOI: 10.2174/1871527314666150317224155
The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
, 14(7): 838 - 854Kurt Lucas, Gerwyn Morris, George Anderson and Michael Maes
DOI: 10.2174/1871527314666150317224645
Effects of Chronic Lamotrigine Administration on Maximal Electroshock- Induced Seizures in Mice
, 14(7): 855 - 862Monika Banach and Kinga Kornel Borowicz
DOI: 10.2174/1871527314666150225141642
Evoked Potential in Panic Disorder Patients: A Systematic Review
, 14(7): 863 - 871Luiza Medeiros Wanick Di Giorgio, Bruna Brandao Velasques, Pedro Ribeiro, Antonio Egidio Nardi and Marcele Regine de Carvalho
DOI: 10.2174/1871527314666150303164539
Reactive Astrogliosis: Role in Alzheimer's Disease
, 14(7): 872 - 879Priti Jain, Pankaj Kumar Wadhwa and Hemant Ramanlal Jadhav
DOI: 10.2174/1871527314666150713104738
The Role of Toll-Like Receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A New Promising Therapeutic Approach?
, 14(7): 903 - 914Maria Elsa Gambuzza, Francesca Maria Salmeri, Luca Soraci, Giulia Soraci, Vincenza Sofo, Silvia Marino and Placido Bramanti
DOI: 10.2174/1871527314666150325235247
Defining and Regulating Acute Inflammatory Lesion Formation during the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
, 14(7): 915 - 935Christopher Bolton and Paul Smith
DOI: 10.2174/1871527314666150716103629
Telomeric Repeat Containing RNA (TERRA): Aging and Cancer
, 14(7): 936 - 946Sonam Sinha, Samriddhi Shukla, Sajid Khan, Mohammad Farhan, Mohammad Amjad Kamal and Syed Musthapa Meeran
DOI: 10.2174/1871527314666150317230124
Lewy Bodies: A Spectator or Salient Killer?
, 14(7): 947 - 955Jeswinder Sian-Hulsmann, Camelia Monoranu, S. Strobel and Peter Riederer
DOI: 10.2174/1871527314666150317225659
  |
Editor-in-Chief
Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
Italy
Biography
View Full Editorial Board
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
Italy
Biography
Biography of Edoardo Spina
Dr. Spina graduated in Medicine, specialized in Neurology and in Psychiatry at the University of Messina, Italy. He obtained a doctorate (Ph.D) in Clinical Pharmacology at Karolinska Institute, Stockholm. Currently, Dr. Spina is Professor of Pharmacology at the Department of Clinical and Experimental Medicine, University of Messina. His main scientific interest is clinical neuropsychopharmacology. Dr. Spina authored more than 200 articles in international journals and 2 books. He is Associate Editor of Frontiers in Pharmacogenetics and member of the editorial board of Therapeutic Drug Monitoring, Basic & Clinical Pharmacology & Toxicology and Neuropsychiatric Disease and Treatment.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Scopus CiteScore Metrics: 2.72
Advertisement
Webmaster Contact: info@benthamscience.net